165 related articles for article (PubMed ID: 38271373)
1. CT-based screening of sarcopenia and its role in cachexia syndrome in pancreatic cancer.
Khristenko E; Sinitsyn V; Rieden T; Girod P; Kauczor HU; Mayer P; Klauss M; Lyadov V
PLoS One; 2024; 19(1):e0291185. PubMed ID: 38271373
[TBL] [Abstract][Full Text] [Related]
2. Clinical impact of sarcopenia on prognosis in pancreatic ductal adenocarcinoma: A retrospective cohort study.
Ninomiya G; Fujii T; Yamada S; Yabusaki N; Suzuki K; Iwata N; Kanda M; Hayashi M; Tanaka C; Nakayama G; Sugimoto H; Koike M; Fujiwara M; Kodera Y
Int J Surg; 2017 Mar; 39():45-51. PubMed ID: 28110029
[TBL] [Abstract][Full Text] [Related]
3. Skeletal Muscle Depletion Predicts the Prognosis of Patients with Advanced Pancreatic Cancer Undergoing Palliative Chemotherapy, Independent of Body Mass Index.
Choi Y; Oh DY; Kim TY; Lee KH; Han SW; Im SA; Kim TY; Bang YJ
PLoS One; 2015; 10(10):e0139749. PubMed ID: 26437072
[TBL] [Abstract][Full Text] [Related]
4. Sarcopenia and sarcopenic obesity are independent adverse prognostic factors in resectable pancreatic ductal adenocarcinoma.
Gruber ES; Jomrich G; Tamandl D; Gnant M; Schindl M; Sahora K
PLoS One; 2019; 14(5):e0215915. PubMed ID: 31059520
[TBL] [Abstract][Full Text] [Related]
5. Enhancing evaluation of sarcopenia in patients with non-small cell lung cancer (NSCLC) by assessing skeletal muscle index (SMI) at the first lumbar (L1) level on routine chest computed tomography (CT).
Recio-Boiles A; Galeas JN; Goldwasser B; Sanchez K; Man LMW; Gentzler RD; Gildersleeve J; Hollen PJ; Gralla RJ
Support Care Cancer; 2018 Jul; 26(7):2353-2359. PubMed ID: 29417293
[TBL] [Abstract][Full Text] [Related]
6. Deep learning-based assessment of CT markers of sarcopenia and myosteatosis for outcome assessment in patients with advanced pancreatic cancer after high-intensity focused ultrasound treatment.
Nowak S; Kloth C; Theis M; Marinova M; Attenberger UI; Sprinkart AM; Luetkens JA
Eur Radiol; 2024 Jan; 34(1):279-286. PubMed ID: 37572195
[TBL] [Abstract][Full Text] [Related]
7. Assessment of muscle mass using chest computed tomography-based quantitative and qualitative measurements in patients with systemic sclerosis: A retrospective study with cross-sectional and longitudinal analyses.
da Rocha DS; Tessari JA; Mainardi NB; Hax V; Gasparin AA; de Oliveira CAV; Garcia TS; Xavier RM; Chakr RMDS
Semin Arthritis Rheum; 2023 Apr; 59():152168. PubMed ID: 36736023
[TBL] [Abstract][Full Text] [Related]
8. Clinical significance of skeletal muscle density and sarcopenia in patients with pancreatic cancer undergoing first-line chemotherapy: a retrospective observational study.
Kim IH; Choi MH; Lee IS; Hong TH; Lee MA
BMC Cancer; 2021 Jan; 21(1):77. PubMed ID: 33461517
[TBL] [Abstract][Full Text] [Related]
9. The effect of sarcopenia and sarcopenic obesity on survival in gastric cancer.
Şahin MEH; Akbaş F; Yardimci AH; Şahin E
BMC Cancer; 2023 Sep; 23(1):911. PubMed ID: 37770828
[TBL] [Abstract][Full Text] [Related]
10. Computed Tomographic Sarcopenia in Pancreatic Cancer: Further Utilization to Plan Patient Management.
Jalal M; Campbell JA; Wadsley J; Hopper AD
J Gastrointest Cancer; 2021 Sep; 52(3):1183-1187. PubMed ID: 34292498
[TBL] [Abstract][Full Text] [Related]
11. Influence of cachexia and sarcopenia on survival in pancreatic ductal adenocarcinoma: a systematic review.
Ozola Zalite I; Zykus R; Francisco Gonzalez M; Saygili F; Pukitis A; Gaujoux S; Charnley RM; Lyadov V
Pancreatology; 2015; 15(1):19-24. PubMed ID: 25524484
[TBL] [Abstract][Full Text] [Related]
12. Body composition measurements and clinical outcomes in patients with resectable pancreatic adenocarcinoma - analysis from SWOG S1505.
Sohal DPS; Boutin RD; Lenchik L; Kim J; Beg MS; Wang-Gillam A; Wade JL; Guthrie KA; Chiorean EG; Ahmad SA; Lowy AM; Philip PA; Chang VT
J Gastrointest Surg; 2024 Mar; 28(3):232-235. PubMed ID: 38445914
[TBL] [Abstract][Full Text] [Related]
13. Predicting the Overall Survival in Patients with Advanced Pancreatic Cancer by Calculating L3 Skeletal Muscle Index Derived from CT.
Özkul B; Özkul Ö; Bilir C
Curr Med Imaging; 2022; 18(10):1079-1085. PubMed ID: 35240961
[TBL] [Abstract][Full Text] [Related]
14. The impact of sarcopenia and myosteatosis on outcomes of unresectable pancreatic cancer or distal cholangiocarcinoma.
Rollins KE; Tewari N; Ackner A; Awwad A; Madhusudan S; Macdonald IA; Fearon KC; Lobo DN
Clin Nutr; 2016 Oct; 35(5):1103-9. PubMed ID: 26411749
[TBL] [Abstract][Full Text] [Related]
15. Associations of body composition parameters with postoperative outcome and perineural tumour invasion after oncological pancreatic resection.
Mueller TC; Henselmann M; Reischl S; Jaeger C; Trefzer C; Demir IE; Friess H; Martignoni ME
BMC Surg; 2024 Jun; 24(1):175. PubMed ID: 38835067
[TBL] [Abstract][Full Text] [Related]
16. Comparing Western and Eastern criteria for sarcopenia and their association with survival in patients with pancreatic cancer.
Wu CH; Chang MC; Lyadov VK; Liang PC; Chen CM; Shih TT; Chang YT
Clin Nutr; 2019 Apr; 38(2):862-869. PubMed ID: 29503056
[TBL] [Abstract][Full Text] [Related]
17. Thoracic skeletal muscle index is effective for CT-defined sarcopenia evaluation in patients with head and neck cancer.
Vangelov B; Smee R; Moses D; Bauer J
Eur Arch Otorhinolaryngol; 2023 Dec; 280(12):5583-5594. PubMed ID: 37573279
[TBL] [Abstract][Full Text] [Related]
18. The differential effects of sarcopenia and cachexia on overall survival for pancreatic ductal adenocarcinoma patients following pancreatectomy: A retrospective study based on a large population.
Shen XD; Wang X; Zheng ZJ; Chen YH; Tan CL; Liu XB; Ke NW
Cancer Med; 2023 May; 12(9):10438-10448. PubMed ID: 36938648
[TBL] [Abstract][Full Text] [Related]
19. Sarcopenia assessed with DXA and CT increases the risk of perioperative complications in patients with gastrectomy.
Kim M; Lee CM; Kang BK; Ha TK; Choi YY; Lee SJ
Eur Radiol; 2023 Jul; 33(7):5150-5158. PubMed ID: 36637463
[TBL] [Abstract][Full Text] [Related]
20. Association of Sarcopenia with a Poor Prognosis and Decreased Tumor-Infiltrating CD8-Positive T Cells in Pancreatic Ductal Adenocarcinoma: A Retrospective Analysis.
Masuda S; Yamakawa K; Masuda A; Toyama H; Sofue K; Nanno Y; Komatsu S; Omiya S; Sakai A; Kobayashi T; Tanaka T; Tsujimae M; Ashina S; Gonda M; Abe S; Uemura H; Kohashi S; Inomata N; Nagao K; Harada Y; Miki M; Irie Y; Juri N; Kanzawa M; Itoh T; Fukumoto T; Kodama Y
Ann Surg Oncol; 2023 Sep; 30(9):5776-5787. PubMed ID: 37191859
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
